Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2013 Jul 2;5(5):449–468. doi: 10.1002/wnan.1233

Figure 5.

Figure 5

PLGA-b-PLL-g-PEG NPs contain siRNA, two drugs, and three ligands for targeting, cell penetration, and trafficking. Reprinted from Biomaterials, 33/2, Zhou et al, Octa-functional PLGA nanoparticles for targeted and efficient siRNA delivery to tumors, 177–186,122 Copyright (2012), with permission from Elsevier.